Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels

Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and one of the major causes of cardiovascular morbidity and mortality. Despite good progress within the past years, safe and effective treatment of AF remains an unmet clinical need. The anti-anginal agent ranolazin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratte, Antonius, Wiedmann, Felix, Kraft, Manuel, Katus, Hugo A., Schmidt, Constanze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988797/
https://www.ncbi.nlm.nih.gov/pubmed/32038227
http://dx.doi.org/10.3389/fphar.2019.01367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988797/
https://www.ncbi.nlm.nih.gov/pubmed/32038227
http://dx.doi.org/10.3389/fphar.2019.01367

Ejemplares similares